Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.640
+0.040 (1.11%)
At close: Dec 19, 2025, 4:00 PM EST
3.680
+0.040 (1.10%)
After-hours: Dec 19, 2025, 7:58 PM EST
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $644.42 million as of December 19, 2025. Its market cap has increased by 58.32% in one year.
Market Cap
644.42M
Enterprise Value
549.27M
1-Year Change
58.32%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $644.42M, a decrease of -60.40%. That is a compound annual growth rate of -25.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 644.42M | 72.96% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |